D.N. Louis, A. Perry, P. Wesseling, D.J. Brat, I.A. Cree, D. Figarella-Branger, C. Hawkins et al. The 2021 WHO classification of tumors of the central nervous system: A Summary. Neuro-Oncol. 23(8), 1231–1251 (2021). https://doi.org/10.1093/neuonc/noab106

Article  CAS  PubMed  PubMed Central  Google Scholar 

N. Karavitaki, C. Brufani, J.T. Warner, C.B.T. Adams, P. Richards, O. Ansorge, B. Shine, H.E. Turner, J.A.H. Wass, Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin. Endocrinol. 62(4), 397–409 (2005). https://doi.org/10.1111/j.1365-2265.2005.02231.x

Article  CAS  Google Scholar 

M.J. Diaz, S.H. Kwak, K.T. Root, A. Fadil, A. Nguyen, L. Ladehoff, S. Batchu, B. Lucke-Wold, Current approaches to craniopharyngioma management. Front. Biosci. (Landmark Ed.) 27(12), 328 (2022). https://doi.org/10.31083/j.fbl2712328

Article  CAS  PubMed  Google Scholar 

E.M. Erfurth, Endocrine aspects and sequel in patients with craniopharyngioma. J. Pediatr. Endocrinol. Metab.: JPEM 28(1–2), 19–26 (2015). https://doi.org/10.1515/jpem-2014-0419

Article  PubMed  Google Scholar 

A.M. Pereira, E.M. Schmid, P.J. Schutte, J.H.C. Voormolen, N.R. Biermasz, S.W. van Thiel, E.P.M. Corssmit, J.W.A. Smit, F. Roelfsema, J.A. Romijn, High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin. Endocrinol. 62(2), 197–204 (2005). https://doi.org/10.1111/j.1365-2265.2004.02196.x

Article  Google Scholar 

A. Serbis, V.R. Tsinopoulou, A. Papadopoulou, S. Kolanis, E.I. Sakellari, K. Margaritis, E. Litou et al. Predictive factors for pediatric craniopharyngioma recurrence: an extensive narrative review. Diagnostics (Basel, Switz.) 13(9), 1588 (2023). https://doi.org/10.3390/diagnostics13091588

Article  Google Scholar 

A.S. Sterkenburg, A. Hoffmann, U. Gebhardt, M. Warmuth-Metz, A.M.M. Daubenbüchel, H.L. Müller, Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro-Oncol. 17(7), 1029–1038 (2015). https://doi.org/10.1093/neuonc/nov044

Article  PubMed  PubMed Central  Google Scholar 

Z. Zhou, S. Zhang, F. Hu, Endocrine disorder in patients with craniopharyngioma. Front. Neurol. 12 (2021). https://www.frontiersin.org/articles/10.3389/fneur.2021.737743

Y. Guo, L. Pei, Y. Li, C. Li, S. Gui, M. Ni, P. Liu, Y. Zhang, L. Zhong, Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma. Front. Endocrinol. 14, 1180591 (2023). https://doi.org/10.3389/fendo.2023.1180591

Article  Google Scholar 

G. Patti, E. Calandra, A. De Bellis, A. Gallizia, M. Crocco, F. Napoli, A.M.E. Allegri et al. Antibodies against hypothalamus and pituitary gland in childhood-onset brain tumors and pituitary dysfunction. Front. Endocrinol. 11, 16 (2020). https://doi.org/10.3389/fendo.2020.00016

Article  Google Scholar 

B. Ahmed, C.N. Bairey Merz, B.D. Johnson, V. Bittner, S.L. Berga, G.D. Braunstein, T.K. Hodgson et al. Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the national heart, lung, and blood institute sponsored WISE study). Am. J. Cardiol. 102(2), 150–154 (2008). https://doi.org/10.1016/j.amjcard.2008.03.029

Article  PubMed  PubMed Central  Google Scholar 

C.N. Bairey Merz, B.D. Johnson, B.L. Sharaf, V. Bittner, S.L. Berga, G.D. Braunstein, Hodgson et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: A Report from the NHLBI-Sponsored WISE Study. J. Am. Coll. Cardiol. 41(3), 413–419 (2003). https://doi.org/10.1016/s0735-1097(02)02763-8

Article  PubMed  Google Scholar 

N.A. Tritos, S.L. Greenspan, D. King, A. Hamrahian, D.M. Cook, P.J. Jönsson, M.P. Wajnrajch, M. Koltowska-Häggstrom, B.M.K. Biller, Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: A KIMS database analysis. J. Clin. Endocrinol. Metab. 96(5), 1516–1523 (2011). https://doi.org/10.1210/jc.2010-2662

Article  CAS  PubMed  PubMed Central  Google Scholar 

H. Holmer, V. Popovic, B. Ekman, C. Follin, A.B. Siversson, E.M. Erfurth, Hypothalamic involvement and insufficient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma. Eur. J. Endocrinol. 165(1), 25–31 (2011). https://doi.org/10.1530/EJE-11-0229

Article  CAS  PubMed  Google Scholar 

D. Matthews, L. Bath, W. Högler, A. Mason, A. Smyth, M. Skae, Hormone supplementation for pubertal induction in girls. Arch. Dis. Child. 102(10), 975–980 (2017). https://doi.org/10.1136/archdischild-2016-311372

Article  PubMed  Google Scholar 

K.K. Miller, G. Sesmilo, A. Schiller, D. Schoenfeld, S. Burton, A. Klibanski, Androgen deficiency in women with hypopituitarism. J. Clin. Endocrinol. Metab. 86(2), 561–567 (2001). https://doi.org/10.1210/jcem.86.2.7246

Article  CAS  PubMed  Google Scholar 

C. Olivius, K. Landin-Wilhelmsen, D.S. Olsson, G. Johannsson, Å. Tivesten, Prevalence and treatment of central hypogonadism and hypoandrogenism in women with hypopituitarism. Pituitary 21(5), 445–453 (2018). https://doi.org/10.1007/s11102-018-0895-1

Article  PubMed  Google Scholar 

N. Pluchino, A. Carmignani, A. Cubeddu, A. Santoro, V. Cela, T. Errasti, Androgen therapy in women: For whom and when. Arch. Gynecol. Obstet. 288(4), 731–737 (2013). https://doi.org/10.1007/s00404-013-2969-7

Article  CAS  PubMed  Google Scholar 

I. Ilovayskaya, V. Zektser, L. Lazebnik, Similarity of female central (hypogonadotropic) hypogonadism and postmenopause. Climacteric: J. Int. Menopause Soc. 20(4), 356–361 (2017). https://doi.org/10.1080/13697137.2017.1315086

Article  CAS  Google Scholar 

K.K. Miller, B.M.K. Biller, C. Beauregard, J.G. Lipman, J. Jones, D. Schoenfeld, J.C. Sherman, B. Swearingen, J. Loeffler, A. Klibanski, Effects of testosterone replacement in androgen-deficient women with hypopituitarism: A randomized, double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 91(5), 1683–1690 (2006). https://doi.org/10.1210/jc.2005-2596

Article  CAS  PubMed  Google Scholar 

H. Zang, S.R. Davis, Androgen replacement therapy in androgen-deficient women with hypopituitarism. Drugs 68(15), 2085–2093 (2008). https://doi.org/10.2165/00003495-200868150-00001

Article  CAS  PubMed  Google Scholar 

T. Tsilchorozidou, G.S. Conway, Uterus size and ovarian morphology in women with isolated growth hormone deficiency, hypogonadotrophic hypogonadism and hypopituitarism. Clin. Endocrinol. 61(5), 567–572 (2004). https://doi.org/10.1111/j.1365-2265.2004.02126.x

Article  Google Scholar 

H. Okinaga, A. Matsuno, R. Okazaki, High risk of osteopenia and bone derangement in postsurgical patients with craniopharyngiomas, pituitary adenomas and other parasellar lesions. Endocr. J. 52(6), 751–756 (2005). https://doi.org/10.1507/endocrj.52.751

Article  PubMed  Google Scholar 

N.A. Tritos, A.H. Hamrahian, D. King, S.L. Greenspan, D.M. Cook, P.J. Jönsson, M.P. Wajnrajch, M. Koltowska-Häggstrom, B.M.K. Biller, A longer interval without gh replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: A KIMS database analysis. Eur. J. Endocrinol. 167(3), 343–351 (2012). https://doi.org/10.1530/EJE-12-0070

Article  CAS  PubMed  PubMed Central  Google Scholar 

P. Dimitri, Treatment of acquired hypothalamic obesity: Now and the future. Front. Endocrinol. 13, 846880 (2022). https://doi.org/10.3389/fendo.2022.846880

Article  Google Scholar 

M. Hage, O. Plesa, I. Lemaire, M.L. Raffin Sanson, Estrogen and progesterone therapy and meningiomas. Endocrinology 163(2), bqab259 (2022). https://doi.org/10.1210/endocr/bqab259

Article  CAS  PubMed  Google Scholar 

A. Martínez-Ortega, Á. Flores-Martinez, E. Venegas-Moreno, E. Dios, D. Del Can, E. Rivas, A. Kaen et al. Sex hormone receptor expression in craniopharyngiomas and association with tumor aggressiveness characteristics. J. Clin. Med. 11(1), 281 (2022). https://doi.org/10.3390/jcm11010281

Article  CAS  PubMed  PubMed Central  Google Scholar 

M. Fleseriu, I.A. Hashim, N. Karavitaki, S. Melmed, M.H. Murad, R. Salvatori, M.H. Samuels, Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(11), 3888–3921 (2016). https://doi.org/10.1210/jc.2016-2118

Article  CAS  PubMed  Google Scholar 

P.M. Mah, J. Webster, P. Jönsson, U. Feldt-Rasmussen, M. Koltowska-Häggström, R.J.M. Ross, Estrogen replacement in women of fertile years with hypopituitarism. J. Clin. Endocrinol. Metab. 90(11), 5964–5969 (2005). https://doi.org/10.1210/jc.2005-1207

Article  CAS  PubMed  Google Scholar 

N. Phelan, S.H. Conway, S. Llahana, G.S. Conway, Quantification of the adverse effect of ethinylestradiol containing oral contraceptive pills when used in conjunction with growth hormone replacement in routine practice. Clin. Endocrinol. 76(5), 729–733 (2012). https://doi.org/10.1111/j.1365-2265.2011.04277.x

Article  CAS  Google Scholar 

M.V. Dragoman, The combined oral contraceptive pill- recent developments, risks and benefits. Best. Pract. Res. Clin. Obstet. Gynaecol. 28(6), 825–834 (2014). https://doi.org/10.1016/j.bpobgyn.2014.06.003

Article  PubMed  Google Scholar 

V. Birzniece, K.K.Y. Ho, Growth and development: patching up a better pill for GH-deficient women. Nat. Rev. Endocrinol. 8(4), 197–198 (2012). https://doi.org/10.1038/nrendo.2012.9

Article  CAS  PubMed  Google Scholar 

N. Shoung, K.K.Y. Ho, Managing estrogen therapy in the pituitary patient. J. Endocr. Soc. 7(5), bvad051 (2023). https://doi.org/10.1210/jendso/bvad051

Article  CAS  PubMed  PubMed Central  Google Scholar 

S. Khosla, D.G. Monroe, Regulation of bone metabolism by sex steroids. Cold Spring Harb. Perspect. Med. 8(1), a031211 (2018). https://doi.org/10.1101/cshperspect.a031211

Article